PMV Pharmaceuticals, Inc. (PMVP)

Nasdaq · Pharmaceutical Preparations · Inc. DE

What they're doing

Between 2026-06-21 and 2026-09-19, public records show 1 signal for PMV Pharmaceuticals, Inc.. Most notable: 2026-09-02: Filed 8-K disclosing material agreement. Federal contract obligations over the last 24 months total $0. This summary was assembled automatically from SEC EDGAR, USAspending.gov, U.S. Senate lobbying disclosures and Wikimedia pageview counts.

Generated 2026-09-19 from public records.

Signals, last 12 months

  1. Material 8-K filing
    Filed 8-K disclosing material agreement
  2. Large insider sale
    OrbiMed Capital GP V LLC (ten_percent_owner) sold $1.5M of stock

Insider transactions

DateInsiderRoleCodeSharesPriceValue
2025-10-27Mack David HenrydirectorM220,6431.37$302,281
2025-10-23OrbiMed Capital GP V LLCten percent ownerS1,000,0001.52$1,520,000
2025-09-10ORBIMED ADVISORS LLCten percent ownerS500,0001.8$900,000
2025-07-01Ticktin RobertofficerS23,1511.06$24,540
2025-07-01Jalota DeepikaofficerS33,0651.06$35,049
2025-07-01Carulli MichaelofficerS28,2491.06$29,944
2025-07-01Mack David HenrydirectorS58,4111.06$61,916
2025-01-03Mack David HenrydirectorM17,7090.53$9,386
2024-12-03Mack David HenrydirectorM91,7500.53$48,628
2024-09-11Carulli MichaelofficerS2,8911.5$4,337
2024-09-11Jalota DeepikaofficerS7,2181.5$10,827

Federal contracts

No federal contract actions on record for this recipient mapping.

Lobbying

No federal lobbying filings on record for this client mapping.

Public attention

No Wikipedia pageview data linked to this company.

Recent filings